Sam Chun Dang Pharm Co Ltd (000250)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sam Chun Dang Pharm Co Ltd (000250) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013614
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sam Chun Dang Pharm Co Ltd (SCD) is a research and development company that discovers and develops drugs. The company offers products in the therapeutic areas of ophthalmology, cardiovasculars, endocrinology, gastrointestines, antibacterials, anti-fungals, antivirals, respiratory, antiinflammatories, antihistamines, musculoskeletals, and vitamines. Its ophthalmic drugs provides dry eye therapies, antibiotic eye drops, glaucoma therapeutics, shandong and snow cycloplegic, diabetic retinopathy, anti-bacterial and anti-inflammatory complexes, anti-inflammatory eye drops, allergic conjunctivitis therapeutics, and cataract therapeutics, among others. SCD conducts research activities for developing modified drugs for incurable diseases such as diabetes and hyperlipidemia. It also performs formulation and ocular permeation research. SCD is headquartered in Seoul, South Korea.

Sam Chun Dang Pharm Co Ltd (000250) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 11
Taiwan Liposome Enters Into Distribution Agreement With Sam Chun Dang Pharm For AmBiL 12
Debt Offering 13
Sam Chun Dang Pharm Completes Public Offering Of Bonds For US$7 Million 13
Acquisition 14
Sam Chun Dang Pharm Acquires 61.27% stake In DHP Korea For US$13 Million 14
Sam Chun Dang Pharm Co Ltd – Key Competitors 15
Sam Chun Dang Pharm Co Ltd – Key Employees 16
Sam Chun Dang Pharm Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sam Chun Dang Pharm Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Sam Chun Dang Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Breckenridge Pharma Enters into Agreement with Sam Chun Dang Pharm 11
Taiwan Liposome Enters Into Distribution Agreement With Sam Chun Dang Pharm For AmBiL 12
Sam Chun Dang Pharm Completes Public Offering Of Bonds For US$7 Million 13
Sam Chun Dang Pharm Acquires 61.27% stake In DHP Korea For US$13 Million 14
Sam Chun Dang Pharm Co Ltd, Key Competitors 15
Sam Chun Dang Pharm Co Ltd, Key Employees 16
Sam Chun Dang Pharm Co Ltd, Other Locations 17

★海外企業調査レポート[Sam Chun Dang Pharm Co Ltd (000250)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nayara Energy Ltd.:企業の戦略・SWOT・財務分析
    Nayara Energy Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nayara Energy Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Seven Generations Energy Ltd (VII):企業の財務・戦略的SWOT分析
    Seven Generations Energy Ltd (VII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • University of Maryland Medical Center Corp:企業の戦略的SWOT分析
    University of Maryland Medical Center Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • ADC Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary ADC Therapeutics SA (ADCT) is a pharmaceutical company that develops a pipeline of proprietary antibody drug conjugates for the treatment of both solid and hematological cancers. The company offers combining monoclonal antibodies specific to particular types of tumor cells with a novel class …
  • Medikit Co Ltd (7749):企業の製品パイプライン分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …
  • Heritage Provider Network Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Heritage Provider Network Inc (HPN) is a managed care organization that offers medical care services. The organization operates through medical care group, urgent care centers and affiliated health plans. It offers patient care services such as urgent care, pharmacy, lab, radiology, pediatri …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務情報
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Maruho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • Power Finance Corp Ltd (PFC):企業の財務・戦略的SWOT分析
    Power Finance Corp Ltd (PFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Guangdong Electric Power Development Co Ltd (000539):電力:M&Aディール及び事業提携情報
    Summary Guangdong Electric Power Development Co., Ltd. (Guangdong Electric) is a leading china based electricity distribution company. The company is a subsidiary of Guangdong Yudean Group Co., Ltd. Guangdong Electric is engaged in developing electric power plants in the country. The company is also …
  • Central Iowa Power Cooperative:企業の戦略的SWOT分析
    Central Iowa Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Mexan Limited
    Mexan Limited - Strategy, SWOT and Corporate Finance Report Summary Mexan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • BASF SE (BAS):石油・ガス:M&Aディール及び事業提携情報
    Summary BASF SE (BASF) is a chemical company, which carries out the research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additive …
  • GKN Aerospace Services Ltd:企業の戦略的SWOT分析
    GKN Aerospace Services Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Atossa Genetics Inc:企業のM&A・事業提携・投資動向
    Atossa Genetics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atossa Genetics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • MEG Energy Corp (MEG):石油・ガス:M&Aディール及び事業提携情報
    Summary MEG Energy Corp (MEG) is an oil and gas company that develops and produces from oil sands. The company operates Christina lake, May River and Surmont project. Its technologies comprise steam-assisted gravity drainage, cogeneration, Hi-Q field pilot and eMSAGP. MEG's Christina Lake project is …
  • Loral Space & Communications Inc. (LORL):企業の財務・戦略的SWOT分析
    Loral Space & Communications Inc. (LORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Holtec International Inc:電力:M&Aディール及び事業提携情報
    Summary Holtec International, Inc. (Holtec) is a diversified energy technology company. It supplies equipment and systems for the nuclear, solar, geothermal and fossil power generation sectors of the energy industry. The company’s products and service portfolio includes advanced technology solutions …
  • AorTech International Plc (AOR):製薬・医療:M&Aディール及び事業提携情報
    Summary AorTech International plc (AorTech) is an Intellectual Property (IP) holding company. It develops and commercializes biologically stable polymers for next generation medical devices. It provides a broad range of polyurethane technologies for applications in cardiovascular surgery, interventi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆